Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Government Affairs Strategy, Market Access, Public Policy Analysis, HTA Planning, Pricing and Reimbursement
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing and Reimbursement, Health Technology Assessment (HTA), Oncology, Stakeholder Management
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Affairs Strategy, Oncology, Stakeholder Management, KOL Engagement, Product Launch
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory Operations, eCTD Publishing, Veeva Vault RIM, DocuBridge, EMA IRIS Platform
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Epidemiology, Pharmacoepidemiology, Oncology, Real-World Evidence, Biostatistical Methods
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Contracting, Launch Readiness, Market Access, Pharmaceutical Law, Team Leadership
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory Affairs, Labelling, Oncology, EU Regulations, EMA
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Congress Strategy, Event Execution, Project Management, Cross-functional Leadership, Vendor Management
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: CRM Management, Omnichannel Enablement, Business Analysis, Stakeholder Management, Veeva CRM
Universitätsbibliothek BaselBasel, Basel-City, Switzerland · Hybrid
Pensum: nach Absprache, mit Flexibilität in der Ausgestaltung zur guten Vereinbarkeit mit dem Studium, befristet vom 1.10.2026 bis vsl. 30.09.2027, bezahltes Praktikum gemäss den Vorgaben der Universität Basel für Forsch…
Skills: Clinical Research, Data Management, German Language Proficiency, REDCap, Excel
Basel, Basel-City, Switzerland · On-site
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who …
Skills: Visitor Management, Customer Service, Communication
Basel, Basel-City, Switzerland · On-site
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who …
Skills: Downstream Processing, Biotechnological Drug Substance Manufacturing, Buffer and Media Preparation, Tech Transfer, Scale-up/down Activities
Basel, Basel-City, Switzerland · On-site
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who …
Skills: Synthetic Organic Chemistry, Laboratory Digitalization, Automation Technology, Liquid Handling, Solid Dosing
Basel, Basel-City, Switzerland · On-site
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who …
Skills: Executive Communications, Strategic Planning, People Leadership, Public Affairs, Media Relations
Basel, Basel-City, Switzerland · On-site
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who …
Skills: Patent Litigation, Pharmaceutical Law, European Patent Law, UPC Strategy, Multi-jurisdictional Litigation
Basel, Basel-City, Switzerland · On-site
In unserer Rehaklinik in Basel behandeln wir Patientinnen und Patienten besonders im Bereich der internistischen und onkologischen Rehabilitation durch moderne und patientenzentrierte Versorgung. Zur Gewährleistung eines…
Skills: Room Service, Hospitality Management, Hygiene Standards, Quality Standards, Customer Service
Basel, Basel-City, Switzerland · On-site
Salary Range: Job Description Summary Chemie- und Pharmatechnologen sind die Produktionsspezialisten in der pharmazeutischen und chemischen Industrie. Sie bedienen computergesteuerte Anlagen, in denen hochwertige pharmaz…
Skills: Technical Understanding, Chemistry, Physics, Technology, Plant Operation
Basel, Basel-City, Switzerland · On-site
Salary Range: Job Description Summary Laborantinnen und Laboranten der Fachrichtung Biologie erforschen und entwickeln neue Medikamente zusammen mit Wissenschaftlerinnen und Wissenschaftlern aus den Bereichen Biochemie, …
Skills: Biochemistry, Biology, Medicine, Pharmaceutical Testing, Cell Culture
Basel, Basel-City, Switzerland · On-site
Salary Range: CHF 0.00 - CHF 0.00 Job Description Summary Als Laborant/in EFZ Chemie entwickelst du durch Experimente neue Wirkstoffe für Medikamente. Du arbeitest mit modernen Laborgeräten, führst chemische Analysen dur…
Skills: Chemical Analysis, Quality Control, Laboratory Documentation, Precision Working, Observation
Universitätsbibliothek BaselBasel, Basel-City, Switzerland · On-site
Preferred starting date is November 1, 2026. The Faculty of Psychology is one of seven faculties of the oldest university in Switzerland. With our core focus on Society & Choice and Health & Interventions, we are success…
Skills: Developmental Psychology, Metacognitive Monitoring, R Programming, Statistical Analysis, Longitudinal Research Design
Basel, Basel-City, Switzerland • Hybrid
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Build and lead the European government affairs strategy to support patient access and launch readiness for oncology therapies. This role involves shaping policy priorities, engaging with external stakeholders, and collaborating with cross-functional teams to align policy insights with business goals.
Requires a bachelor's degree and over 12 years of progressive experience in government affairs or market access within the biopharmaceutical industry. Candidates must have a deep understanding of European oncology policy, HTA, and a proven network of policy stakeholders.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Revolution Medicines is seeking an Executive Director, Government Affairs, Europe to build and lead the company's government affairs strategy across Europe as the organization prepares for potential oncology launches and a growing regional presence.This leader will be responsible for shaping and executing European government affairs priorities that support patient access, launch readiness, and long-term value for RevMed's innovative oncology portfolio. The role will focus on the evolving EU and country-level policy environment, including oncology access, pricing and reimbursement, HTA, innovation incentives, regulatory and legislative developments, and health system sustainability.
The Executive Director will be a key member of the Market Access leadership team to ensure that policy insights and external engagement are directly connected to access strategy, HTA planning, reimbursement, country launch sequencing, and stakeholder engagement. The role will partner closely with Corporate Communications / Corporate Affairs, Regulatory, Medical Affairs, Commercial, Legal, Compliance, Patient Advocacy, and global colleagues to ensure consistent and coordinated engagement across the company.
This is a highly strategic, externally facing role for a senior leader who can establish the function, advise the business, represent RevMed credibly with policy stakeholders and industry associations, and translate the European policy landscape into practical business implications and opportunities.
Key Responsibilities:
Develop and lead the European government affairs strategy in alignment with Market Access, commercial readiness, global policy priorities, and RevMed's mission to serve patients with RAS-addicted cancers.
Monitor, analyze, and communicate EU and country-level policy developments that may affect oncology innovation, HTA, pricing and reimbursement, patient access, clinical research, diagnostics, data, and launch execution.
Provide strategic counsel to European and global leadership on policy risks, opportunities, and implications for launch planning, value strategy, access sequencing, and stakeholder engagement.
Establish and maintain strong working relationships with relevant policymakers, government officials, industry associations, professional organizations, patient organizations, and other external stakeholders, in close coordination with the Patient Advocacy function and consistent with company policies and applicable laws.
Serve as the policy lead within the Market Access team, ensuring European policy perspectives are embedded into HTA readiness, payer engagement planning, value communication, reimbursement strategy, and country-level access plans.
Work closely with Corporate Communications / Corporate Affairs to align policy positions, external messaging, reputation considerations, and issues management across European stakeholders.
Represent RevMed in relevant European and national trade associations, policy forums, and coalitions, and ensure internal teams are informed of key outputs and opportunities for engagement.
Partner with Legal and Compliance to ensure all government affairs activities comply with applicable rules, transparency requirements, codes of practice, and company standards.
Establish operating processes, governance, and internal communication mechanisms for the European government affairs function, including policy tracking, stakeholder mapping, briefing materials, and leadership updates.
Contribute to cross-functional launch readiness and scenario planning by anticipating policy and access barriers and identifying opportunities to support timely and sustainable patient access.
Partner with global, regional, and affiliate RevMed leadership to develop aligned access plans and to lead a policy and access community, enabling the sharing of best practices, experiences, and priorities across markets.
Bachelor's degree required; advanced degree in public policy, law, political science, health economics, life sciences, public health, or a related field preferred.
12+ years of progressive experience in government affairs, public policy, market access, healthcare policy, or related roles within the biopharmaceutical industry, trade associations, government, consulting, or a relevant healthcare organization.
Demonstrated experience developing and executing government affairs strategies in Europe, including understanding of both EU institutions and national healthcare systems.
Strong knowledge of European oncology policy, HTA, pricing and reimbursement, market access, innovation policy, and the evolving policy environment affecting medicines and patient access.
Proven ability to translate complex policy developments into clear strategic implications for access, reimbursement, launch readiness, and business decision-making.
Existing network within European healthcare policy, oncology policy, access, or biopharmaceutical trade association communities.
Established credibility engaging with senior internal leaders and external stakeholders, including policymakers, trade associations, patient organizations, and healthcare policy influencers.
Experience working cross-functionally with Market Access, Corporate Communications / Corporate Affairs, Commercial, Medical Affairs, Regulatory, Legal, Compliance, and global teams.
Excellent written and verbal communication skills, including the ability to prepare executive briefings, policy positions, stakeholder materials, and concise leadership updates.
Strong judgment, political acumen, integrity, and ability to operate in a highly regulated environment with appropriate discretion and compliance discipline.
Ability to thrive in a fast-paced, entrepreneurial biotechnology environment and to build capabilities, processes, and external presence from an early-stage foundation.
Experience supporting oncology, precision medicine, molecular diagnostics, or highly innovative specialty medicines.
Prior experience with European launch readiness and country-level access planning in major markets such as Germany, France, Italy, Spain, the United Kingdom, and/or Switzerland.
Experience working in a smaller or rapidly scaling biotechnology company, including building a new function or operating model.
Multilingual capability and/or direct experience working across multiple European cultures and healthcare systems.
Comfort operating at both strategic and hands-on levels, from board or executive-level briefings to detailed policy tracking and stakeholder mapping.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-Hybrid #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineThere are currently 319 open healthcare positions in Basel, Switzerland listed on Clera. New openings are added daily as companies post roles.
Companies currently hiring include Roche, Novartis, Revolution Medicine, ZURZACH Care Unternehmensgruppe, Medbase Gruppe, among others. Browse the listings above to see every active employer.
Yes — 110 of the 319 open healthcare positions offer remote or hybrid work (5 remote, 105 hybrid).
Each listing links directly to the employer's application page. Apply early — fresh listings get the most recruiter attention in the first two weeks.
